IRWD
Ironwood Pharmaceuticals Inc
3.60$
-3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | 97.7 | 19.2 | 17.0 | 13.0 | 17.3 | 12.7 | 4.1 | 4.1 | 3.7 | 4.5 | 12.3 | 11.4 | 13.1 | 10.8 | – | – | – | – | 112.2 | – | 802.1 | – | – | 8.1 | 25.2 | 5.7 | 5.4 | |
| 8.0 | 7.0 | 8.1 | 8.7 | 6.8 | 6.3 | 6.2 | 7.3 | 7.6 | 3.9 | 5.1 | 4.6 | 3.1 | 4.9 | 3.7 | 3.9 | 3.6 | 4.7 | 4.6 | 5.1 | 5.2 | 4.7 | 5.7 | 5.1 | 4.6 | 5.6 | 4.7 | 3.9 | 4.1 | 4.0 | 3.3 | 2.6 | 1.7 | 2.0 | 0.8 | 0.4 | 0.7 | 2.0 | 1.6 | 1.8 | |
| 32.3 | 28.8 | 71.0 | 483.6 | – | 191.2 | – | – | – | – | – | – | – | – | – | – | 244.3 | 29.4 | 16.5 | 4.1 | 3.7 | 3.2 | 4.6 | 4.0 | 3.2 | 3.5 | 2.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 8.8 | 8.2 | 9.1 | 9.5 | 7.6 | 7.2 | 7.0 | 8.1 | 8.5 | 4.6 | 5.9 | 5.5 | 3.7 | 5.4 | 4.1 | 4.3 | 3.9 | 4.9 | 4.6 | 5.0 | 4.9 | 4.3 | 5.5 | 4.9 | 4.1 | 5.0 | 3.9 | 5.3 | 5.6 | 5.4 | 4.7 | 3.9 | 3.1 | 3.4 | 2.3 | 2.0 | 2.0 | 3.3 | 2.6 | 2.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 41.1 | 23.3 | 14.6 | 13.6 | 10.5 | 13.1 | 10.0 | 9.7 | 8.9 | 7.7 | 9.5 | 8.6 | 7.2 | 7.8 | 6.0 | 8.4 | 10.0 | 11.5 | 12.8 | 12.8 | 11.0 | 12.1 | 9.3 | 6.3 | 4.6 | 8.0 | 4.6 | 4.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 594.0 | 17.7 | 13.9 | 10.3 | 11.0 | 9.2 | 9.3 | 8.7 | 7.4 | 9.5 | 8.0 | 7.4 | 8.4 | 6.8 | 6.3 | 7.9 | 9.7 | 9.3 | 7.1 | 5.3 | 6.8 | 3.1 | 3.9 | 3.4 | 4.8 | 5.2 | 3.7 | |
| -6.8% | -6.7% | -7.5% | -3.5% | -5.7% | -5.5% | -5.5% | -4.1% | -4.1% | -5.9% | -5.3% | -4.5% | -1.1% | 0.2% | 5.7% | 7.2% | 9.7% | 9.1% | 10.9% | 10.8% | 11.5% | 13.5% | 10.6% | 12.5% | 13.5% | 11.9% | 14.8% | 16.0% | 12.6% | 10.3% | 10.8% | 14.2% | 18.8% | 14.7% | 32.5% | 25.7% | 29.3% | 21.0% | 19.2% | 26.7% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 54.5% | 62.4% | 72.5% | 84.0% | 95.9% | 93.5% | 93.2% | 93.4% | 93.4% | 90.6% | 91.0% | 89.5% | 92.1% | 94.4% | 94.3% | 96.6% | 91.1% | 93.5% | 90.3% | 87.8% | 90.5% | 90.6% | 91.9% | 94.6% | 97.2% | 97.1% | 99.7% | 95.1% | 95.2% | 95.4% | 88.9% | 93.4% | 85.3% | 84.2% | 82.0% | 81.3% | 91.6% | 90.4% | 99.6% | 99.8% | |
| -21.4% | -18.9% | -34.5% | -42.6% | -36.5% | -25.9% | -23.3% | -21.9% | -71.6% | -68.9% | -74.3% | -53.3% | 9.0% | 19.3% | 34.2% | 37.8% | 35.4% | 36.7% | 44.0% | 50.2% | 54.9% | 56.1% | 57.9% | 56.6% | 56.7% | 61.0% | 60.6% | -207.4% | -209.6% | -211.6% | -238.4% | 30.5% | 26.2% | 26.5% | 16.7% | 23.7% | 36.9% | 33.8% | 55.8% | 60.6% | |
| -34.3% | -29.8% | -46.5% | -53.0% | -48.9% | -39.2% | -34.1% | -34.0% | -82.1% | -81.5% | -86.2% | -64.5% | -9.7% | 5.0% | 19.1% | 22.7% | 27.8% | 27.3% | 35.8% | 123.2% | 128.3% | 127.7% | 124.8% | 41.6% | 39.8% | 42.6% | 43.6% | -214.7% | -220.2% | -226.4% | -254.4% | 2.3% | -0.7% | 0.3% | -10.2% | -2.6% | 8.4% | 8.1% | 28.3% | 33.4% | |
| -54.2% | -47.3% | -60.6% | -30.6% | -38.9% | -34.8% | -34.0% | -30.1% | -30.9% | -22.9% | -26.8% | -20.6% | -3.6% | 0.8% | 20.8% | 27.8% | 35.2% | 42.9% | 49.8% | 55.1% | 60.2% | 63.2% | 59.7% | 63.7% | 61.6% | 66.6% | 69.4% | 61.6% | 52.4% | 41.4% | 35.8% | 36.5% | 32.7% | 29.4% | 24.7% | 9.7% | 20.0% | 42.9% | 31.0% | 47.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -138.3% | -122.5% | -408.0% | -2,945.3% | – | -1,187.4% | – | – | – | – | – | – | – | – | – | – | 1,877.2% | 169.5% | 129.6% | 99.4% | 91.4% | 87.2% | 101.8% | 32.5% | 28.4% | 26.8% | 25.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -11.2% | -11.5% | -17.2% | -20.3% | -22.8% | -19.3% | -18.8% | -18.2% | -61.2% | -85.0% | -82.1% | -75.0% | -12.5% | 5.3% | 20.8% | 21.9% | 22.5% | 19.0% | 23.8% | 50.5% | 49.1% | 46.9% | 48.7% | 17.7% | 16.1% | 15.9% | 15.8% | -152.1% | -181.7% | -212.8% | -239.8% | 2.3% | -0.6% | 0.3% | -9.9% | -2.3% | 7.2% | 6.1% | 23.5% | 45.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 195 | 319 | 256 | 211 | 234 | 274 | 259 | 262 | 268 | 241 | 299 | 315 | 273 | 232 | 183 | 167 | 118 | 69 | -1.0 | -48 | -124 | -163 | -75 | -107 | -177 | -257 | -342 | 625 | 615 | 609 | 555 | 521 | 514 | 499 | 479 | 495 | 447 | 372 | 368 | 309 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 6.9 | 2.3 | 1.5 | 1.2 | 0.8 | 0.5 | 0.0 | -0.2 | -0.5 | -0.7 | -0.3 | -0.5 | -0.7 | -1.0 | -1.3 | 2.3 | 2.6 | 2.9 | 3.7 | 4.3 | 4.8 | 5.0 | 6.2 | 5.1 | 3.0 | 3.0 | 1.8 | 1.3 | |
| 8.1% | 9.4% | 4.2% | 0.7% | -2.8% | 1.6% | -3.2% | -7.1% | -47.4% | -59.1% | -65.2% | -69.5% | -45.8% | -23.2% | -17.7% | -8.3% | 1.2% | 11.2% | 18.4% | 50.8% | 53.7% | 53.8% | 47.8% | 54.6% | 56.8% | 59.3% | 61.2% | -57.3% | -61.7% | -73.5% | -75.3% | -81.3% | -79.9% | -85.9% | -102.1% | -89.9% | -66.7% | -66.0% | -50.0% | -56.8% | |
| 6.4 | 5.6 | 13.1 | 80.7 | – | 40.6 | – | – | – | – | – | – | – | – | – | – | 72.4 | 6.9 | 4.0 | 0.9 | 0.8 | 0.8 | 1.0 | 0.7 | 0.7 | 0.6 | 0.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.57 | -0.54 | -0.82 | -0.96 | -0.95 | -0.78 | -0.71 | -0.74 | -1.66 | -1.83 | -1.93 | -1.52 | -0.27 | 0.14 | 0.53 | 0.61 | 0.69 | 0.66 | 0.88 | 3.11 | 3.21 | 3.19 | 2.78 | 0.94 | 0.91 | 0.95 | 0.97 | -5.90 | -5.10 | -6.42 | -6.67 | 0.06 | -0.02 | 0.01 | -0.20 | -0.05 | 0.16 | 0.14 | 0.61 | 0.78 | |
| 1.66 | 1.83 | 1.76 | 1.82 | 1.95 | 1.99 | 2.09 | 2.18 | 2.02 | 2.25 | 2.23 | 2.36 | 2.76 | 2.71 | 2.75 | 2.67 | 2.49 | 2.41 | 2.45 | 2.53 | 2.50 | 2.50 | 2.23 | 2.25 | 2.28 | 2.22 | 2.23 | 2.75 | 2.31 | 2.84 | 2.62 | 2.52 | 2.36 | 2.19 | 1.97 | 1.91 | 1.91 | 1.67 | 2.17 | 2.35 | |
| 0.41 | 0.44 | 0.20 | 0.03 | -0.12 | 0.07 | -0.12 | -0.29 | -1.29 | -1.27 | -1.53 | -1.41 | -0.98 | -0.59 | -0.45 | -0.23 | 0.04 | 0.39 | 0.68 | 3.13 | 3.51 | 3.66 | 2.73 | 2.88 | 3.20 | 3.52 | 3.79 | -2.23 | -1.73 | -2.22 | -2.10 | -2.02 | -1.94 | -1.88 | -2.08 | -1.91 | -1.49 | -1.47 | -1.30 | -0.98 | |
| -0.90 | -0.86 | -1.07 | -0.56 | -0.76 | -0.69 | -0.71 | -0.66 | -0.62 | -0.52 | -0.60 | -0.49 | -0.10 | 0.02 | 0.57 | 0.74 | 0.88 | 1.03 | 1.22 | 1.39 | 1.50 | 1.58 | 1.33 | 1.43 | 1.40 | 1.48 | 1.55 | 1.70 | 1.21 | 1.17 | 0.94 | 0.92 | 0.77 | 0.64 | 0.49 | 0.19 | 0.38 | 0.71 | 0.67 | 1.12 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.